Ideal for pilot-scale applications, Virosart® Max* mid-scale capsules support integration into existing pilot-scale setups with minimal training required, facilitating seamless scale-up. With their advanced filtration technology and user-friendly design, these capsules offer efficient virus filtration with advanced adsorptive pre-filtration, ensuring robust virus removal and membrane protection.
Key Features
- Advanced Filtration Technology: Triple layer Polyamide membrane with 0.1 µm nominal pore size for superior filtration efficiency.
- Efficient Aggregate Binding: Binds aggregates and small hydrophobic molecules effectively.
- High Adsorptive Capacity: Optimized triple-layer membrane for maximum performance.
- Enhanced Membrane Protection: Increases robustness and protects the final virus retentive membranes.
- Integrity Testing: Each unit is integrity tested and complies with industry standards, ensuring reliability and performance.
- Regulatory compliance: Quality Assurance: ISO 9001 certified Quality Management System and Non-pyrogenic as per USP Bacterial Endotoxins standards.
Versatile Formats: Available in various sizes to accommodate different process volumes and flow rates.
Virosart® Max Capsule®:
Available filtration area: 220 cm2 (0.24 ft²)
Virosart® Max Midicaps®
Available filtration area: 0.21 m2 (2.3 ft²)
* The patented technology (DE 10 2011 105 525 B4) binds aggregates efficiently through hydrophobic interactions with polyamide, independently of process conditions such as conductivity from biological feed streams (mAbs, plasma derivates or recombinant proteins).
